Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Annual Review of Physiology|July 7, 2009
Transcriptional control of mitochondrial biogenesis and functionM Benjamin Hock, Anastasia KralliThe Journal of Biological Chemistry|May 10, 2003
Nuclear factor of activated T cells 2 transactivation in mast cells: a novel isoform-specific transactivation domain confers unique FcepsilonRI responsivenessM Benjamin Hock, Melissa A BrownThe Journal of Biological Chemistry|July 17, 2007
Coactivators PGC-1beta and SRC-1 interact functionally to promote the agonist activity of the selective estrogen receptor modulator tamoxifenDieter Kressler, M Benjamin Hock, Anastasia KralliThe AAPS Journal|November 9, 2014
Immunogenicity of antibody drug conjugates: bioanalytical methods and monitoring strategy for a novel therapeutic modalityM Benjamin Hock, Karen E Thudium, Montserrat Carrasco-Triguero, et al.Journal of Immunological Methods|April 2, 2013
Biomarkers for non-human primate type-I hypersensitivity: antigen-specific immunoglobulin E assaysDarcey Clark, Faith Shiota, Carla Forte, et al.The AAPS Journal|March 2, 2017
A Proposal to Redefine Clinical Immunogenicity AssessmentDaniel T Mytych, M Benjamin Hock, Mark Kroenke, et al.Proceedings of the National Academy of Sciences of the United States of America|January 19, 2007
Orphan nuclear receptor estrogen-related receptor alpha is essential for adaptive thermogenesisJosep A Villena, M Benjamin Hock, William Y Chang, et al.The Journal of Physiology|April 14, 2011
Striated muscle activator of Rho signalling (STARS) is a PGC-1α/oestrogen-related receptor-α target gene and is upregulated in human skeletal muscle after endurance exerciseMarita A Wallace, M Benjamin Hock, Bethany C Hazen, et al.Toxicologic Pathology|November 19, 2013
Immunogenicity/hypersensitivity of biologicsMichael W Leach, James B Rottman, M Benjamin Hock, et al.Journal of Immunological Methods|March 10, 2017
Clinical immunogenicity of the d-amino acid peptide therapeutic etelcalcetide: Method development challenges and anti-drug antibody clinical impact assessmentsMark A Kroenke, Dohan K Weeraratne, Hongjie Deng, et al.Pageof 3